S. Yasser and M. Hesham, “Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus”, Am. J. Chem. Pharm., vol. 1, no. 2, pp. 1–4, Oct. 2022.